8 March 2022 - Advanced therapy medicinal products are highly innovative therapies. Their costs and uncertain value claims have raised concerns ...
11 November 2021 - The Dutch healthcare institute Zorginstituut Nederland is going to increase its monitoring of treatment to better ...
2 September 2021 - Patients in the Netherlands have to wait an average of 510 days for access to a new ...
2 August 2021 - Idefiris (imlifidase) for enabling kidney transplantation in highly sensitised patients is now reimbursable and available for use ...
10 May 2021 - In a challenge to Novartis, a Dutch advisory body has recommended that the government not cover ...
7 May 2021 - A drug to treat a rare muscle disease which affects some 20 children in the Netherlands ...
5 October 2020 - Treatments that have not been proven effective will be removed from the Netherlands' basic health insurance package, ...
7 July 2020 - Dutch government commission on compulsory licensing was nearly sabotaged last month after one of its members ...
7 May 2020 - Subcutaneous rheumatoid arthritis treatment Remsima SC launched in the Netherlands, its third European market, Celltrion Healthcare ...
31 January 2020 - In economic evaluation, the healthcare perspective has gradually given way to use of the societal perspective, as ...
15 October 2019 - If pharmaceutical companies rapidly inflate the price of their products, is there an alternative? One Dutch chemist ...
31 August 2019 - As medicines become more numerous and often more expensive, health care professionals seek new ways to understand ...
28 August 2019 - In an unusual move, the Netherlands health minister wrote an open letter to the pharmaceutical industry ...
27 August 2019 - Health minister Bruno Bruins has warned the pharmaceuticals industry that he considers the way drugs firms ...
15 July 2019 - Lessons from early deployments in The Netherlands. ...